Literature DB >> 19349359

The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation.

Danislav S Spassov1, Frederick L Baehner, Ching Hang Wong, Stephen McDonough, Mark M Moasser.   

Abstract

The roles of epithelial cells encompass both cellular- and tissue-level functions that involve numerous cell-cell and cell-matrix interactions, which ultimately mediate the highly structured arrangement of cells on a basement membrane. Although maintaining this basic structure is critical for preserving tissue integrity, plasticity in epithelial cell behavior is also critical for processes such as cell migration during development or wound repair, mitotic cell detachment, and physiological shedding. The mechanisms that mediate epithelial cell plasticity are only beginning to be understood. We previously identified Trask, a transmembrane protein that is phosphorylated by src kinases during mitosis. In this study, we report that the phosphorylation of Trask is associated with anchorage loss in epithelial cells. Phosphorylation of Trask is seen during the cell-detachment phase of mitosis, in experimentally induced interphase detachment, and during cell migration in experimental epithelial models. An analysis of human tissues shows that Trask is widely expressed in many epithelial tissues but not in most tissues of mesenchymal origin, except for a subset of early hematopoietic cells. Trask is not phosphorylated in epithelial tissues in vivo; however, its phosphorylation is seen in epithelial cells undergoing mitosis or physiological shedding. Trask is a novel epithelial membrane protein that is phosphorylated by src kinases when epithelial cells disengage from their tissue framework, identifying an important new regulator of epithelial tissue dynamics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349359      PMCID: PMC2671264          DOI: 10.2353/ajpath.2009.080890

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  CDCP1 is a novel marker for hematopoietic stem cells.

Authors:  Tim Conze; Reiner Lammers; Selim Kuci; Marwa Scherl-Mostageer; Norbert Schweifer; Lothar Kanz; Hans-Jorg Buhring
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

2.  Mitosis-specific phosphorylation of p60c-src by p34cdc2-associated protein kinase.

Authors:  D O Morgan; J M Kaplan; J M Bishop; H E Varmus
Journal:  Cell       Date:  1989-06-02       Impact factor: 41.582

3.  Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer.

Authors:  M Scherl-Mostageer; W Sommergruber; R Abseher; R Hauptmann; P Ambros; N Schweifer
Journal:  Oncogene       Date:  2001-07-19       Impact factor: 9.867

4.  Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS.

Authors:  Magali André; Jean-Pierre Le Caer; Céline Greco; Sébastien Planchon; Wassim El Nemer; Claude Boucheix; Eric Rubinstein; Julia Chamot-Rooke; François Le Naour
Journal:  Proteomics       Date:  2006-03       Impact factor: 3.984

5.  Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model.

Authors:  Amara C Siva; Martha A Wild; Richard E Kirkland; Mary Jean Nolan; Bing Lin; Toshiaki Maruyama; Ferda Yantiri-Wernimont; Shana Frederickson; Katherine S Bowdish; Hong Xin
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

6.  CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.

Authors:  Takamasa Uekita; Lin Jia; Mako Narisawa-Saito; Jun Yokota; Tohru Kiyono; Ryuichi Sakai
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

Review 7.  Src and the control of cell division.

Authors:  S J Taylor; D Shalloway
Journal:  Bioessays       Date:  1996-01       Impact factor: 4.345

8.  CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma.

Authors:  Takamasa Uekita; Masamitsu Tanaka; Misato Takigahira; Yuri Miyazawa; Yukihiro Nakanishi; Yae Kanai; Kazuyoshi Yanagihara; Ryuichi Sakai
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

9.  Altered phosphorylation and activation of pp60c-src during fibroblast mitosis.

Authors:  I Chackalaparampil; D Shalloway
Journal:  Cell       Date:  1988-03-25       Impact factor: 41.582

Review 10.  The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Authors:  Jonathan M Lee; Shoukat Dedhar; Raghu Kalluri; Erik W Thompson
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

View more
  24 in total

1.  Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling.

Authors:  Danislav S Spassov; Ching Hang Wong; Natalia Sergina; Deepika Ahuja; Michael Fried; Dean Sheppard; Mark M Moasser
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

2.  Trask phosphorylation defines the reverse mode of a phosphotyrosine signaling switch that underlies cell anchorage state.

Authors:  Danislav S Spassov; Ching H Wong; Mark M Moasser
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

3.  CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.

Authors:  Hui Liu; Shao-En Ong; Kwabena Badu-Nkansah; Jeffrey Schindler; Forest M White; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

4.  The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.

Authors:  C H Benes; G Poulogiannis; L C Cantley; S P Soltoff
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

5.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

6.  Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.

Authors:  Gwendlyn Kollmorgen; Gerhard Niederfellner; Alexander Lifke; Gloria J Spohn; Natascha Rieder; Suzana Vega Harring; Frieder Bauss; Helmut Burtscher; Reiner Lammers; Birgit Bossenmaier
Journal:  Mol Oncol       Date:  2013-09-03       Impact factor: 6.603

7.  CD318/CUB-domain-containing protein 1 expression on cord blood hematopoietic progenitors.

Authors:  Hiromi Takeda; Yoshihiro Fujimori; Shunro Kai; Hiroyasu Ogawa; Takashi Nakano
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

8.  Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.

Authors:  Yaowu He; Andreas Wortmann; Les J Burke; Janet C Reid; Mark N Adams; Ibtissam Abdul-Jabbar; James P Quigley; Richard Leduc; Daniel Kirchhofer; John D Hooper
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

9.  Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cells.

Authors:  Danislav S Spassov; Ching Hang Wong; Sunny Y Wong; Jeremy F Reiter; Mark M Moasser
Journal:  Cancer Res       Date:  2012-12-12       Impact factor: 12.701

10.  Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.

Authors:  Brooke M Emerling; Cyril H Benes; George Poulogiannis; Eric L Bell; Kevin Courtney; Hui Liu; Rayman Choo-Wing; Gary Bellinger; Kazumi S Tsukazawa; Victoria Brown; Sabina Signoretti; Stephen P Soltoff; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.